Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
+3.94M
-
Total reported value, excl. options
-
$291M
-
Value change
-
+$40.8M
-
Put/Call ratio
-
0.6
-
Number of buys
-
52
-
Number of sells
-
-31
-
Price
-
$10.19
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q2 2023
100 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q2 2023.
scPharmaceuticals Inc. - Common Stock (SCPH) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 53.4M outstanding shares and own 53.48% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.56M shares), RTW INVESTMENTS, LP (3.3M shares), AIGH Capital Management LLC (2.05M shares), COWEN AND COMPANY, LLC (1.84M shares), BlackRock Inc. (1.73M shares), MILLENNIUM MANAGEMENT LLC (1.22M shares), 5AM Venture Management, LLC (1.2M shares), VANGUARD GROUP INC (1.19M shares), MORGAN STANLEY (1.16M shares), and STATE STREET CORP (1.02M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.